ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY)

CUSIP: 02043Q107

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
131,516,365
Total 13F shares
55,704,223
Share change
+88,448
Total reported value
$3,739,161,613
Put/Call ratio
215%
Price per share
$67.14
Number of holders
193
Value change
+$8,742,143
Number of buys
110
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP 02043Q107?
CUSIP 02043Q107 identifies ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2014

As of 31 Mar 2014, ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,704,223 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, GILDER GAGNON HOWE & CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., and State Street Corp. This page lists 193 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.